Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Puneet Singh Image

      Puneet Singh, MD, MS, FACS, FSSO, CMQ

      Department of Breast Surgical Oncology, Division of Surgery

      Meet Puneet Singh, M.D.

      In the News

      Unidentified woman sits facing a mirror

      How to manage body image concerns after breast cancer surgery

      Puneet Singh, M.D., performs breast cancer surgery.

      Lumpectomy: 7 things to know


      Cancerwise Podcast
      Cancerwise Podcast

      Featured Podcast:

      Body image after breast cancer surgery

      Puneet Singh, M.D., and Deepti Chopra, M.B.B.S., discuss the ways surgery can impact a patient and how providers help patients navigate the changes.

      View podcast episode page
      Read transcript

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Fellowship Program Director, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2023McGovern Medical School, The University of Texas, Houston, Texas, US, Clinical Research, M.S
      2011Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, US, M.D
      2007Washington University in St. Louis, St. Louis, Missouri, US, Biology, A.B

      Postgraduate Training

      2018-2019Clinical Fellowship, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2015-2018Senior Fellowship, Clinical Medical Ethics, The University of Chicago, Chicago, Illinois
      2014-2015Fellowship, Clinical Medical Ethics, The University of Chicago, Chicago, Illinois
      2013-2015Research Fellowship, The University of Chicago, Chicago, Illinois
      2011-2018Residency, General Surgery, The University of Chicago, Chicago, Illinois

      Licenses & Certifications

      2024American Board of Medical Quality
      2023Basic Life Support
      2023Georgia Composite Medical Board
      2023Washington State Department of Health
      2023Tennessee Board of Medical Examiners
      2023Arizona Board of Medical Examiners
      2023Oklahoma State Board of Medical Licensure
      2023Alabama Board of Medical Examiners
      2023Mississippi State Board of Medical Licensure
      2023Louisiana State Board of Medical Examiners
      2018American Board of Surgery
      2018Federal Drug Enforcement Administration
      2018Florida Board of Medicine
      2018Texas Medical Board
      2013IL Licensed Physician and Surgeon

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Breast Surgical Oncology, Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2025

      Administrative Appointments/Responsibilities

      Fellowship Program Director, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024 - Present

      Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2025

      Other Professional Positions

      Associate Program Director of Breast Surgical Oncology Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2023

      Intramural Institutional Committee Activities

      Member, MDACC: Breast Center Delays Communication Working Group, The University of Texas MD Anderson Cancer Center, 2020 - 2021

      Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Appointed Member, Clinical Ethics Consultation Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Editorial Activities

      Member of Editorial Review Board, Surgical Oncology Insight, 2023 - Present

      Honors & Awards

      2023Breast Surgical Faculty Excellence in Clinical Teaching Award
      2017Trauma Resident of the Year, Cook County Trauma Unit
      2016Annual Resident Award: Outcomes Winner, Chicago Surgical Society
      2015Huggins Research Award, The University of Chicago Department of Surgery
      2015Resident Scholarship for the 2015 Leadership and Advocacy Summit
      2014Annual Resident Award: Honorable Mention, Chicago Surgical Society
      2012Academic Achievement Award, The University of Chicago Department of Surgery
      2004National Residence Hall Honorary 2004 Service Award
      2003 - 2007Dean's List, Washington University in St. Louis

      Professional Memberships

      Society of University Surgeons

      2026 - Present

      Annals of Surgical Oncology

      2022 - Present

      Association for Academic Surgery

      2022 - Present

      American College of Surgeons- South Texas Chapter

      2022 - Present

      American Society of Clinical Oncology

      2020 - Present

      American College of Surgeons

      2020 - Present

      Translational Breast Cancer Research Consortium

      2020 - Present

      Society of Asian Academic Surgeons

      2019 - Present

      American Society of Breast Surgeons

      2019 - Present

      Association of Women Surgeons

      2018 - Present

      Society of Surgical Oncology

      2018 - Present

      Association of American Medical Colleges

      2016 - 2018

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Special Session: Highlights from SABCS 2024. BSO Panelist. Invited. Breast Cancer Clinical and Translational Research ( BCCTR) Conference. Houston, Texas, US.

      Regional Presentations

      1. 2026. Advances in Approaches to Local-Regional Disease. Invited. Best of SABCS South. Atlanta, GA, US.
      2. 2024. Ethics Session: Communicating Patient Safety Concerns: How Trainees and Other Health Professionals Raise Concerns to Supervising Physicians. Invited. South Texas Chapter ACS Joint Annual Meeting. Houston, TX, US.
      3. 2023. Trainee Communication of Errors and Near Misses. Invited. South Texas Advanced Symposium on Trauma and Clinical Care. McAllen, TX, US.
      4. 2023. Burnout in the EMS Profession. Invited. South Texas Advanced Symposium on Trauma and Clinical Care. McAllen, TX, US.
      5. 2023. Ethics Session: Surgical Informed Consent in a Transforming Healthcare Environment. Invited. North & South Texas Chapters ACS Joint Annual Meeting. Austin, TX, US.
      6. 2022. Error Disclosure in Surgery. Invited. Error Disclosure in Surgery. McAllen, TX, US.
      7. 2022. Ethics Session: Surgeon Disclosure of Error. Invited. SoTX ACS Annual Meeting. Austin, TX, US.
      8. 2018. Update on the 2017 San Antonio Breast Cancer Symposium. Summary of “Phase II Single Arm Study of Preoperative Letrozole for ER(+) Postmenopausal DCIS.”. Invited. San Antonio Breast Cancer Symposium. Evanston, IL, US.
      9. 2017. Update on the 2016 San Antonio Breast Cancer Symposium. Summary of “DCIS biological risk profile and its risk of recurrence after breast conservation.”. Invited. Evanston, IL, US.
      10. 2016. Survival in DCIS Patients Undergoing Surgery versus patients not undergoing surgery. Chicago Surgical Society Annual Resident Awards Meeting. Chicago, IL, US.
      11. 2015. Analysis of subcutaneous fat depot secretomes sampled during autologous breast reconstruction for cancer. The University of Chicago Department of Surgery's Charles B. Huggins 22nd Annual Research Symposium. Chicago, IL, US.
      12. 2014. Concordance of clinical and pathologic staging in breast cancer: Report from the National Cancer Data Base. Chicago Surgical Society Annual Resident Awards Meeting. Chicago, IL, US.
      13. 2008. Autonomic Control of C-reactive Protein:A Population-Based Study. Conference. Society of General Internal Medicine Midwest Regional Meeting. Chicago, IL, US.

      National Presentations

      1. 2025. Role of Sentinel Lymph Node Biopsy and Axillary Dissection. Invited. School of Breast Oncology. Atlanta, GA, US.
      2. 2025. Novel Surgical Approaches to the Axilla and Intraoperative Techniques in the session Innovations in Axillary Lymph Node Management: Optimizing Surgical Approaches in Breast Cancer Care. Invited. American College of Surgeons Clinical Congress 2025. Chicago, Illinois, US.
      3. 2025. Innovation, Industry, and Ethics: Navigating the Future of Surgical Research. Panelist. American College of Surgeons Clinical Congress 2025. Chicago, Illinois, US.
      4. 2024. Discussion of Abstracts GS2-05, GS2-06, GS2-07: Optimizing locoregional treatment of low-risk breast cancer. Invited. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
      5. 2024. Role of Sentinel Lymph Node Biopsy and Axillary Dissection. Invited. School of Breast Oncology. Atlanta, GA, US.
      6. 2024. What do I do When I Go Home? Updates in the Surgical Management of Breast Cancer. Invited. National Consortium of Breast Centers 33rd Annual Interdisciplinary Breast Center Conference. Las Vegas, NV, US.
      7. 2023. Less is More: Minimizing Surgical Treatment in Patients with Early-Stage Breast Cancer: Poster Discussion PS01-Abstracts 06-10. Invited. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
      8. 2023. Role of Sentinel Lymph Node Biopsy and Axillary Dissection. Invited. School of Breast Oncology. Atlanta, Georgia, US.
      9. 2023. Ethics Colloquium: Safety or Sabotage? Using the Guise of Safety to Report/Write-up Physicians Rather than Resolving Issues through Discussion. Invited. American College of Surgeons Clinical Congress 2023. Boston, MA, US.
      10. 2023. Factors predicting volume of axillary nodal disease in clinically-node positive, ER+/Her2- breast cancer. Conference. American Radium Society. Maui, HI, US.
      11. 2023. Are we overdoing social media? Is it overwhelming? Knowing your limits. Invited. Society for Surgery of the Alimentary Tract. Chicago, IL, US.
      12. 2023. Management of lobular neoplasia diagnosed via MRI-guided biopsy. Poster. American Society of Breast Surgeons 24th Annual Meeting. Boston, MA, US.
      13. 2023. Neoadjuvant Radiation Therapy. Invited. The American Society of Breast Surgeon 24th Annual Meeting. Boston, MA, US.
      14. 2023. Meet the Experts: Controversies in Breast Cancer Surgery. Invited. Society of Surgical Oncology 2023 Annual Meeting. Boston, MA, US.
      15. 2022. Role of Sentinel Lymph Node Biopsy and Axillary Dissection. Invited. School of Breast Oncology. Atlanta, GA, US.
      16. 2022. American College of Surgeons Cancer Surgery Standards Program Update. Invited. Quarterly CoC State Chair Town Hall, US.
      17. 2022. A Prospective Clinical Trial of Immediate Breast Reconstruction Following Pre-Mastectomy Radiotherapy for Operable Breast Cancer. Conference. The American Society of Breast Surgeons 23rd Annual Meeting. Las Vegas, NV, US.
      18. 2021. A Framework for Pre-Implementation of CoC Operative Standards. Invited. ACS Quality and Safety Conference, US.
      19. 2020. Informed Consent: Process versus Paper. Presented during: Informed Consent Ruling: Contrary to Ethical Standards or Upholding the Primacy of the Surgeon-Patient Interaction?. Invited. American College of Surgeons Clinical Congress 2020, US.
      20. 2020. Physician Experience and Emergency Surgery: Informed Consent Discussion. Presented during: Ethics Colloquium: Contemporary Challenges to Surgical Informed Consent. Invited. American College of Surgeons Clinical Congress 2020, US.
      21. 2020. Association of a genomic index of sensitivity to endocrine therapy with disease-free survival in breast cancer. Conference. ESMO Breast Cancer 2020.
      22. 2019. Effective Localization of Non-palpable Breast Lesions Using Magseed. ACS Quality and Safe Conference. Washington, DC, US.
      23. 2019. Pre-mastectomy radiotherapy feasibility trial to facilitate immediate autologous breast reconstruction: A prospective cohort within a randomized clinical trial. Poster. American College of Surgeons Scientific Forum. Dallas, TX, US.
      24. 2019. Association of a genomic index of sensitivity to endocrine therapy with locoregional recurrence of breast cancer. Conference. American Society of Breast Surgeons 20th Annual Meeting. Dallas, TX, US.
      25. 2019. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective Trial. Conference. Society of Surgical Oncology 2019 Annual Cancer Symposium. San Diego, CA, US.
      26. 2018. Correlation of Circulating or Disseminated Tumor Cells with the OncotypeDX Recurrence Score. Conference. San Antonio Breast Cancer Symposium 2018. San Antonio, TX, US.
      27. 2017. Clinical node positive disease is a high predictor of pathologically positive nodes: Report from the National Cancer Data Base. Conference. American Society of Breast Surgeons Annual 18th Meeting. Las Vegas, NV, US.
      28. 2017. Repetitio est mater studiorum- A comprehensive and distributed intern surgical skills curriculum. Conference. Association of Program Directors in Surgery 2017 Surgical Education Week. San Diego, CA, US.
      29. 2017. Survival in DCIS patients undergoing surgery versus patients not undergoing surgery. Conference. Academic Surgical Congress 12th Annual Meeting. Las Vegas, NV, US.
      30. 2016. PEER: A novel program for resident-to-resident mentorship. Conference. The Association of Surgical Education 2016 Annual Meeting. Boston, MA, US.
      31. 2016. Analysis of abdominal vs breast adipose depots from human subjects. Conference. ENDO 2016: The Endocrine Society Annual Meeting. Boston, MA, US.
      32. 2016. A pilot surgical ethics curriculum for general surgery residents. Conference. Academic Surgical Congress 11th Annual Meeting. Jacksonville, FL, US.
      33. 2015. Young surgeons on speaking up: When and how surgical trainees voice concerns about supervisors' clinical decisions. Conference. Association of Surgical Education Annual Meeting. Seattle, WA, US.
      34. 2015. Concordance of clinical and pathologic staging in breast cancer: Report from the National Cancer Data Base. Conference. Society of Surgical Oncology 68th Annual Cancer Symposium. Houston, TX, US.
      35. 2015. Fat depot biology in microsurgical autologous breast reconstruction following cancer. Conference. Academic Surgical Congress 10th Annual Meeting. Las Vegas, NV, US.
      36. 2008. Autonomic Control of C-reactive Protein:A Population-Based Study. Conference. Society of General Internal Medicine Midwest Regional Meeting. Chicago, IL, US.

      Formal Peers

      1. 2023. Disclosure of Medical Error. Invited, US.
      2. 2022. Disclosure of Medical Error: Pediatric Lecture Series. Invited, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2024 - 2024
      Title:Innovating Breast Cancer RNA therapy: Mechanisms and Pharmaco-genetic Inhibitors
      Funding Source:DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
      Role:Co-I
      ID:BC230333
      Date: 2022 - 2024
      Title:Paul Calabresi Career Development Award for Clinical Oncology
      Funding Source:NIH/NCI
      Role:PI
      Date: 2022 - 2025
      Title:Institutional Research Grant
      Funding Source:The University of Texas MD Anderson Cancer Center
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Wanis, K, Krasniqi, R, Sun, SX, Resetkova, E, Hwang, RF, Hunt, KK, Candelaria, RP, Huo, L, Singh, P. Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis following Neoadjuvant Therapy in Patients with Clinically Node-Negative, Hormone Receptor-Positive, HER2-Negative Breast Cancer. Annals of surgical oncology 33(8):7237-7243, 2026. e-Pub 2026. PMID: 42135547.
      2. Singh P, Rangel MM, Madrigrano A, Lillemoe HA. Taking Leave During Breast Surgical Oncology Fellowship: A National Evaluation of Policy and Practice. Ann Surg Oncol, 2026. e-Pub 2026. PMID: 42418084.
      3. Singh P, Cohen LN, Seibert D, Kosten T, Wolfrath, N, Ali-Hilli Z, Kantor, O, Teshome M, Blair S, Hieken, T, Wilke, LG, Kothari A, Cortina CS. Streamlining the Abstract Selection Process for the American Society of Breast Surgeons' Annual Meeting by Utilizing Large Language Models. Annals of surgical oncology, 2026. e-Pub 2026. PMID: 42406210.
      4. Chen, J, Wanis, K, Rahman, M, Gianchandani, A, Bedrosian, I, Tamirisa, N, Yi, M, Singareeka Raghavendra, A, Singh, P, Teshome, M, Sun, SX, Kuerer, HM, Hunt, KK, Meric-Bernstam, F, Adesoye, T. Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2− Breast Cancer Undergoing Mastectomy. Annals of surgical oncology 33(7):6414-6421, 2026. e-Pub 2026. PMID: 41949735.
      5. Shaitelman, SF, Krishnamurthy, S, Rauch, GM, Lin, Y, Shen, Y, Valero, V, Johnson, HM, Muruganandham, M, Smith, B, Hoffman, K, Lee, B, Shinn, EH, Symmans, WF, Woodward, W, Mitchell, MP, Goodman, C, Buzdar, AU, Singh, P, Tamirisa, N, Kuerer, HM. Definitive, stereotactic ablative radiotherapy and endocrine therapy without surgery for select low-risk breast cancers. Radiotherapy and Oncology 220, 2026. e-Pub 2026. PMID: 42142534.
      6. Singh P, Rangel M, Tamirisa N, Albarracin,CT, Bevers TB, Sarvet AL, Bedrosian I, Wanis KN. Active monitoring versus surgical excision for atypical ductal hyperplasia. Cancer Prev Res (Phila), 2026. e-Pub 2026. PMID: 42248071.
      7. Lattimore CM, Johnson HM, Kuerer HM, Caudle AS, Giordano SH, Singh P, Hunt KK, Huo L, Wanis KN. Clipped Node Pathology as a Guide for Limited Axillary Surgery in Occult Breast Cancer, 2026. e-Pub 2026.
      8. Leonard L, Yi M, Wingate E, Singh P, Caudle A, Hwang RF, Bedrosian I, Valero V, Litton J, Ibrahim N, Hunt KK. Axillary Management after Neoadjuvant Endocrine Therapy (NET). Ann Surg Oncol 33(4):3327-3337, 2026. e-Pub 2026. PMID: 41455847.
      9. Faber DA, Petcka NL, Singh P, Sur MD, Muralidharan VJ, Langerman A, Schindler N, Delman KA, Srinivasan JK, Angelos P, Postlewait LM. Do Surgical Residents Speak Up About Patient Safety Concerns? A National Survey Assessing Factors Associated With Resident Comfort Level in Raising Concerns to Supervising Physicians. J Surg Educ 83(5):103927, 2026. PMID: 41844047.
      10. Rogers CC, Cohen LN, C Lloren JI, Huang C, Cobb AN, Kong AL, Singh P, Teshome M, Cortina CS. Does neoadjuvant systemic therapy in clinical T1-2 N0 human epidermal growth factor receptor 2-positive breast cancer increase the extent of axillary surgery?. Surgery 191:109907, 2026. e-Pub 2026. PMID: 41387060.
      11. Summerside M, Istl AC, Rogers CC, Cobb AN, Kong AL, Singh P, Cortina CS. From Podium to PubMed: Successful Manuscript Publication of Oral Breast Surgery Abstract Presentations at National Meetings from 2017 to 2022. Ann Surg Oncol 32(11):8184-8191, 2025. e-Pub 2025. PMID: 40684019.
      12. Plichta, JK, Bleicher, RJ, Boughey, JC, Margenthaler, J, Mason, H, Pesce, C, Schulz-Costello, K, Sharma, R, Sweeting, RS, Teshome, M, Leong, W, Carter, WB, Jones, V, Staradub, V, Klimberg, VS, Hoover, S, Boolbol, S, Valente, SA, Downs-Canner, S, Bernik, S, Kumar, S, Willey, SC, Fine, RE, Leong, R, Wooldridge, R, Greenup, R, Singh, P, Borgen, PI, Hansen, N, Dekhne, N, Specht, M, Cowher, MS, Alvarado, M, Milburn, M, McEvoy, M, Cripe, M, Boisvert, ME, Wallace, L, Wiechmann, L, Jacobs, L, Hadzikadic-Gusic, L, Skinner, K, Larson, KE, Tchou, J, Albright, J, Young, J, Bensenhaver, J, Baker, JL, Grumley, J, Jeruss, JS. Analysis of the 2024 Breast Surgical Oncology Fellowship Match. Annals of surgical oncology 32(11):8514-8522, 2025. e-Pub 2025. PMID: 40849385.
      13. Chen JH, Warneke CL, Middleton L, Singh P, Kuerer HM, Hunt KK, Martinez AL, Litton JK, Oke OC, Johnson HM. Complication Rates are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy. Ann Surg Oncol 32(11):8196-8206, 2025. e-Pub 2025. PMID: 40676422.
      14. Huynh V, Glencer A, Yi M, Wingate E, Wingate H, Allassan N, Alameddine S, Singh P, Kuerer HM, Hunt KK, Refinetti AP. Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery. Ann Surg Oncol 32(11):8160-8167, 2025. e-Pub 2025. PMID: 40762776.
      15. Schaverien MV, Singh P, Kuerer HM, Akay CL, Chavez-MacGregor M, Chu CK, Clemens MW, Qiao W, Smith BD, Hoffman KE. Comparison of Outcomes of Microsurgical Breast Reconstruction after Premastectomy and Postmastectomy Radiation Therapy. J Am Coll Surg 241(4):535-549, 2025. e-Pub 2025. PMID: 40366003.
      16. Cohen LN, Rogers CC, Lloren JIC, Kamaraju S, Chaudhary LN, Huang CC, Cobb AN, Singh P, Kong AL, Teshome M, Cortina CS. National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016-2021: The impact of the KATHERINE trial. Breast Cancer Res Treat 212(3):531-543, 2025. e-Pub 2025. PMID: 40459676.
      17. Wanis KN, Mitchell MP, Giordano SH, Litton JK, Shaitelman SF, Tamirisa N, Bedrosian I, Dong W, Shen Y, Hunt KK, Singh P, Sun SX, Caudle AS, Kuerer HM, Meric-Bernstam F, Hwang RF, Adesoye T. Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers. Cancer 131(11):e35910, 2025. e-Pub 2025. PMID: 40433858.
      18. Wanis K, Dong W, Shen Y, Meric-Bernstam F, Adesoye T, Kuerer HM, Caudle AS, Tamirisa N, DeSnyder SM, Sun SX, Bedrosian I, Singh P, Cox SE, Hunt KK, Hwang RF. Predicting pathologic ≥N2 disease in women with breast cancer. NPJ Breast Cancer 11(1), 2025. e-Pub 2025. PMID: 40404657.
      19. Jain, AJ, Schultz, K, Brainerd, MJ, Murimwa, GZ, Fleming, AM, Fackche, N, Bilir, E, Chiba, A, Martin, AN, Singh, P, Childers, CP, Friedman, L, Zafar, SN, Abdelsattar, ZM, Cortina, CS, Stewart, C, Cowher, MD, Ganai, S, Merck, B, Nandakumar, G, Pandalai, P, Narayan, RR, Ahmad, SA. The Top Ten Annals of Surgical Oncology Original Articles on Twitter/X. Ann Surg Oncol 31(13):9100-9111, 2024. e-Pub 2024. PMID: 39138773.
      20. Muppidi, N, Adesoye, T, Yi, M, Sun, SX, Chavez-MacGregor, M, Singh, P, Karuturi, MS, Tamirisa, N, Hunt, KK, Teshome, M. Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol 31(13):8795-8801, 2024. e-Pub 2024. PMID: 39192013.
      21. Wanis, KN, Goetz, L, So, A, Glencer, AC, Sun, SX, Teshome, M, Resetkova, E, Hwang, RF, Hunt, KK, Candelaria, RP, Huo, L, Singh, P. The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol 31(11):7339-7346, 2024. e-Pub 2024. PMID: 39048903.
      22. Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M. Does Neoadjuvant Chemotherapy in Clinical T1-T2 N0 Triple-Negative Breast Cancer Increase the Extent of Axillary Surgery?. Ann Surg Oncol 31(5):3128-3140, 2024. e-Pub 2024. PMID: 38270828.
      23. Everidge, S, Sun, J, Teshome, M, Tamirisa, N, Sun, SX, Adesoye, T, Nia, ES, Bevers, TB, Bedrosian, I, Patel, MM, Singh, P. ASO Visual Abstract. Annals of surgical oncology 31(4):2276-2277, 2024. e-Pub 2024. PMID: 38263369.
      24. Schaverien MV, Singh P, Smith BD, Qiao W, Akay CL, Bloom ES, Chavez-MacGregor M, Chu CK, Clemens MW, Colen JS, Ehlers RA, Hwang RF, Joyner MM, Largo RD, Mericli AF, Mitchell MP, Shuck JW, Tamirisa N, Tripathy D, Villa MT, Woodward WA, Zacharia R, Kuerer HM, Hoffman KE. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial. JAMA Netw Open 7(4):e245217, 2024. e-Pub 2024. PMID: 38578640.
      25. Everidge SA, Sun J, Teshome M, Tamirisa N, Sun S, Adesoye T, Nia E, Bevers T, Bedrosian I, Patel M, Singh P. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol 31(4):2224-2230, 2024. e-Pub 2024. PMID: 38117388.
      26. Sun SX, Piotrowski MJ, Adesoye T, Mitchell MP, Garber HR, Teshome M, Kuerer HM, Tamirisa N, Singh P. Long-term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement. J Am Coll Surg 238(1):1-9, 2024. e-Pub 2024. PMID: 37870227.
      27. Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS. National Trends in Neoadjuvant Chemotherapy Utilization in Patients with Early-Stage Node-Negative Triple-Negative Breast Cancer: The Impact of the CREATE-X Trial. Breast Cancer Res Treat 203(2):317-328, 2024. e-Pub 2024. PMID: 37864105.
      28. Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?. Ann Surg Oncol 30(13):8327-8334, 2023. e-Pub 2023. PMID: 37670121.
      29. Boughey, JC, Yu, H, Dugan, CL, Piltin, MA, Postlewait, LM, Son, JD, Edmiston, K, Godellas, CV, Lee, MC, Carr, MJ, Tonneson, JE, Crown, A, Lancaster, RB, Woriax, HE, Ewing, CA, Chau, HS, Patterson, A, Wong, JM, Alvarado, M, Yang, RL, Chan, TW, Sheade, JB, Ahrendt, GM, Larson, KE, Switalla, K, Tuttle, TM, Tchou, J, Rao, R, Tamirisa, N, Singh, P, Gould, R, Terando, AM, Sauder, C, Hewitt, K, Chiba, A, Esserman, L, Mukhtar, RA. ASO Visual Abstract. Annals of surgical oncology 30(11):6411-6412, 2023. e-Pub 2023. PMID: 37537482.
      30. Boughey JC, Yu H, Dugan CL, Piltin MA, Postlewait L, Son JD, Edmiston KK, Godellas CV, Lee MC, Carr MJ, Tonneson JE, Crown A, Lancaster RB, Woriax HE, Ewing CA, Chau HS, Patterson AK, Wong JM, Alvarado MD, Yang RL, Chan TW, Sheade JB, Ahrendt GM, Larson KE, Switalla K, Tuttle TM, Tchou JC, Rao R, Tamirisa N, Singh P, Gould RE, Terando A, Sauder C, Hewitt K, Chiba A, Esserman LJ, Mukhtar RA. Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial. Ann Surg Oncol 30(11):6401-6410, 2023. e-Pub 2023. PMID: 37380911.
      31. Johnson HM, Teshome M, Singh P, Mitchell KB. Lactation Education for Surgeons: American Society of Breast Surgeons (ASBrS) Survey Demonstrates Strong Member Interest in Expanded Training. Ann Surg Oncol 30(10):6125-6132, 2023. e-Pub 2023. PMID: 37452168.
      32. Mukhtar RA, Chau H, Woriax H, Piltin M, Ahrendt G, Tchou J, Yu H, Ding Q, Dugan CL, Sheade J, Crown A, Carr M, Wong J, Son J, Yang R, Chan T, Terando A, Alvarado M, Ewing C, Tonneson J, Tamirisa N, Gould R, Singh P, Godellas C, Larson K, Chiba A, Rao R, Sauder C, Postlewait L, Lee MC, Symmans WF, Esserman LJ, Boughey JC, Working Group IL. Breast Conservation Surgery and Mastectomy have Similar Locoregional Recurrence Following Neoadjuvant Chemotherapy: Results from 1,462 Patients on the Prospective, Randomized I-SPY2 Trial. Ann Surg 278(3):320-327, 2023. e-Pub 2023. PMID: 37325931.
      33. Carlson KA, Checka C, Hunt KK, Jung J, Bridges C, Singh P, Refinetti A, Moseley T, Perez F, Mayo C, Tamirisa N. Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery. Breast J 2023:9993852, 2023. e-Pub 2023. PMID: 38162957.
      34. Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KK. Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol 29(6):3822-3828, 2022. e-Pub 2022. PMID: 35233742.
      35. Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary Outcomes After Multimodality Therapy in Patients with Breast Cancer Presenting with Ipsilateral Supraclavicular Node Involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
      36. Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KK. Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open 1(2):e008, 2020. e-Pub 2020. PMID: 34017965.
      37. Singh P, Tevis SE, Hall CS, Meas S, Hwang RF, Lucci A. Correlation of Circulating or Disseminated Tumor Cells with the Oncotype DX Recurrence Score. Breast Cancer Res Treat 184(3):683-687, 2020. e-Pub 2020. PMID: 32888140.
      38. Sheckter CC, Singh P, Angelos P, Offodile AC. Surprise Billing in Surgical Care Episodes – Overview, Ethical Concerns, and Policy Solutions in Light of COVID-19. Ann Surg 2020 272(4):e264-e265, 2020. e-Pub 2020.
      39. Singh P, Hoffman K, Schaverien MV, Krause KJ, Butler C, Smith BD, Kuerer HM. Neoadjuvant Radiotherapy to Facilitate Immediate Breast Reconstruction: A Systematic Review and Current Clinical Trials. Ann Surg Oncol 26(10):3312-20, 2019. e-Pub 2019.
      40. Kantor O, Pesce C, Singh P, Miller M, Tseng J, Wang C, Winchester DJ, Yao K. Postmastectomy Radiation Therapy and Overall Survival After Neoadjuvant Chemotherapy. J Surg Oncol 115(6):668-676, 2017. e-Pub 2017.
      41. Volden PA, Skor MN, Johnson MB, Singh P, Patel FN, McClintock MK, Brady MJ, Conzen SD. Mammary Adipose Tissue-Derived Lysophospholipids Promote Estrogen Receptor-Negative Mammary Epithelial Cell Proliferation. Cancer Prev Res 9(5):367-78, 2016. e-Pub 2016.
      42. Sur MD, Schindler N, Singh P, Angelos P, Langerman A. Young Surgeons on Speaking Up: When and How Surgical Trainees Voice Concerns About Supervisors' Clinical Decisions. Am J Surg 211(2):437-44, 2016. e-Pub 2016.
      43. Singh P, Brock CO, Volden PA, Hernandez K, Skor M, Kocherginsky M, Park JE, Brady MJ, Conzen SD. Glucocorticoid receptor ChIP-sequencing of subcutaneous fat reveals modulation of inflammatory pathways. Obesity 23(11):2286-93, 2015. e-Pub 2015.
      44. Singh P, Teng E, Cannon LM, Bello BL, Song DH, Umanskiy K. Dynamic Article: Tandem Robotic Technique of Extralevator Abdominoperenial Excision and Rectus Abdominus Muscle Harvest for Immediate Closure of the Pelvic Floor Defect. Dis Colon Rectum 58(9):885-91, 2015. e-Pub 2015.
      45. Singh P, Kulkarni SA. Is Wide Excision Alone an Appropriate Therapy for DCIS?. Curr Surg. Rep:3, 18, 2015. e-Pub 2015.
      46. Singh P, Bello B, Weber C, Umanskiy K. Rectal Leiomyosarcoma in Association with Ulcerative Colitis: A Rare Condition with an Unusual Presentation. Int J. Colorectal Dis 29(7):887-8, 2014. e-Pub 2014.
      47. Singh P, Hawkley LC, McDade TW, Cacioppo JT, Masi CM. Autonomic Tone and C-reactive Protein: A Prospective Population-based Study. Clinical Autonomic Research 19(6):367-74, 2009. e-Pub 2009.

      Invited Articles

      1. Chen, JH, Singh, P. Locoregional Therapies for Treatment of Invasive Breast Cancer. Current Breast Cancer Reports 16(2):193-203, 2024. e-Pub 2024.
      2. Hoppenot C, Bryan AF, Wightman SC, Yin V, Ferguson BD, Bidadi S, Mitchell MB, Langerman AJ, Angelos P, Singh P. Surgical Informed Consent: New Challenges. Curr Probl Surg 60(2):101258, 2023. e-Pub 2023. PMID: 36813352.
      3. Singh P, Lim B. Targeting Apoptosis in Cancer. Curr Oncol Rep 24(3):273-284, 2022. e-Pub 2022. PMID: 35113355.
      4. Singh P, Kuerer HM. Preoperative Radiotherapy Trials to Facilitate Immediate Breast Reconstruction after Mastectomy. Current Breast Cancer Reports 11:287-292, 2019. e-Pub 2019.
      5. Singh P, Kuerer HM. ASO Author Reflections: Neoadjuvant Radiotherapy Followed by Immediate Breast Reconstruction Represents a Novel Therapeutic Sequence for Breast Cancer. Ann Surg Oncol, 2019. e-Pub 2019.

      Review Articles

      1. Singh, P, Agnese, DM, Amin, M, Barrio, AV, Van Den Bruele, AB, Burke, E, Danforth, DN, Dirbas, FM, Eladoumikdachi, F, Fayanju, OM, Kantor, O, Kumar, S, Lee, MC, Matsen, C, Nguyen, TT, Ozmen, T, Park, KU, Plichta, JK, Reyna, C, Showalter, SL, Styblo, T, Tranakas, N, Weiss, A, Woodfin, AA, Laronga, C, Boughey, JC. Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy. Ann Surg Oncol 32(2):899-911, 2025. e-Pub 2025. PMID: 39538100.
      2. Singh P, Agnese D, Amin M, Barrio AV, Botty Van den Bruele A, Burke E, Danforth DN, Dirbas FM, Eladoumikdachi F, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Laronga C, Boughey J. Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol 31(4):2212-2223, 2024. e-Pub 2024. PMID: 38261126.

      Other Articles

      1. Expert Panel on Breast Imaging, Freer PE, Neal CH, Brown A, Bennett DL, Cassidy MR, Chetlen A, Dibble EH, Giordano SH, Greenwood HI, Hurley J, Ivansco LK, Malak SF, Rauch GM, Reig B, Singh P, Jr SW, Yeh ED, Slanetz PJ ACR Appropriateness Criteria Male Breast Cancer Screening. J Am Coll Radiol 22(11S):S578-2585, 2025. PMID: 41193045.
      2. Huynh, VD, Glencer, AC, Yi, M, Wingate, E, Wingate, H, Allassan, N, Alameddine, S, Singh, P, Kuerer, HM, Hunt, KK, Correa Refinetti, AP Correction. Ann Surg Oncol 32(11):8168, 2025. PMID: 40952542.
      3. Jain, AJ, Schultz, K, Brainerd, MJ, Murimwa, GZ, Fleming, AM, Fackche, N, Bilir, E, Chiba, A, Martin, AN, Singh, P, Childers, CP, Friedman, L, Zafar, SN, Abdelsattar, ZM, Cortina, CS, Stewart, C, Cowher, MD, Ganai, S, Merck, B, Nandakumar, G, Pandalai, P, Narayan, RR, Ahmad, SA Correction to. Ann Surg Oncol 31(13):9112, 2024. PMID: 39313730.
      4. Park K U, Showalter S L, Dirbas Frederick M, Society of Surgical Oncology Breast Disease Site Work Group Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for Breast Cancer. Ann Surg Oncol 31(9):5483-5486, 2024. PMID: 39003374.
      5. Botty van den Bruele A, Weiss Anna, Social of Surgical Oncology Breast Disease Site Work Group Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer. Ann Surg Oncol 31(9):5479-5482, 2024. PMID: 38969855.
      6. Hoppenot, C, Bryan, A, Wightman, SC, Yin, V, Ferguson, BD, Bidadi, S, Mitchell, MB, Langerman, A, Angelos, P, Singh, P In brief. Current problems in surgery 60(2), 2023. PMID: 36813351.

      Book Chapters

      1. Singh P. Surgical Disclosure of Errors. In: Difficult Decisions in Surgical Ethics: An Evidence-Based Approach. 1. Springer, 219-228, 2022.
      2. Postlewait LM, Singh P. Ethical Questions of Surgical Trials. In: Difficult Decisions in Surgical Ethics: An Evidence-Based Approach. 1. Springer, 675-704, 2022.
      3. Singh P, Shen Y, Hunt KK. Trial Design: Overview of Study Designs. In: Success in Academic Surgery: Clinical Trials. 2. Springer International Publishing, 37-45, 2020.
      4. Singh P, Siegler M, Angelos P. Ethical Issues in Surgical Care. In: How to Teach Surgical Ethics. American College of Surgeons, 296-311, 2017.
      5. Shakhsheer BA, Singh P, Gottlieb LJ, Angelos P, Siegler M. The Scar Book: Formation, Mitigation, Rehabilitation, and Prevention. In: Scars and scar management: Ethical considerations. Wolters Kluwer, 49-58, 2017.
      6. Singh P, Kulkarni SA. Surgical Strategies for Breast Cancer Risk Reduction. In: Textbook of Complex General Surgical Oncology. The McGraw-Hill Companies, Inc, 743-750, 2017.
      7. Singh P, Shakhsheer BA, Milner R. Honesty in the perioperative setting: Error and communication. In: Ethical Issues in Anesthesiology and Surgery. Springer International Publishing, 139-149, 2015.

      Books (edited and written)

      1. Singh P, White MG, Ferguson BD. Difficult Decisions in Surgical Oncology. Ed(s) 1. Springer.
      Read More
      Less

      Patient Reviews


      CV information above last modified August 06, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Breast Surgical Oncology Fellowship

      • Breast Surgical Oncology Department

      • Surgery Division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top